News and Current Events
September 20, 2016, NBIA Patient registry is progressing successfully
June 17, 2016, Orphan drug designation granted
The European Medicines Agency (EMA) has granted orphan drug designation to a new candidate compound CAB1803 for the treatment of PKAN, developed by TIRCON partners Acies Bio and University Medical Centre Groningen. For further information, please read the press release.
March 9, 2015, Clinical trial fully randomized
The Clinical trial of Deferiprone in PKAN is now fully randomized.
December 11, 2013, A TIRCON patent has recently been filed
TIRCON partners UMCG and Acies Bio developed a new candidate compound for the treatment of PKAN. For further information, please read the press release.
April, 7-8, 2017, 6th International Symposium on NBIA
The 6th International Symposium on Neurodegeneration with Brain Iron Accumulation & Related Disorders will take place on April 7th and 8th in Stevenson, Washington, USA. For more information, please read the announcement or visit http://bit.ly/NBIASymposium.